Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2784 results

Story / May 04, 2026

Novartis partners with Special Olympics World Winter Games Switzerland 2029

People and Culture

Novartis partners with the Special Olympics to support neuro‑inclusion and build environments where everyone belongs.
Clinical Trials / May 05, 2026

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
Clinical Trials / May 05, 2026

Pediatric Long-Term Follow-up and Rollover Study
Clinical Trials / May 01, 2026

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
Clinical Trials / Apr 29, 2026

Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis
Clinical Trials / Apr 24, 2026

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Clinical Trials / Apr 21, 2026

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population
Clinical Trials / Apr 16, 2026

REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria
Clinical Trials / May 01, 2026

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Clinical Trials / Apr 15, 2026

A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction